Check your level by a blood test
"That variability in sourcing is one of the biggest concerns, particularly when it comes to purity, dosing consistency and overall quality control." The FDA does not allow production of BPC-157, GHK-Cu, KPV and ipamorelin in the U.S., for example, by compounding pharmacies because of safety concerns, so people are ordering them from overseasusually from China
Phase 2, Proliferation (Days 5-21): BPC-157 drives fibroblast proliferation and collagen synthesis
Most compounding pharmacies assign a beyond-use date (BUD) of 28 to 90 days from compounding for refrigerated vials
If you're working with compounds where potency matters
Due to its use of a stabilized spike protein (HexaPro, discussed below), DCFHP is stable at temperatures ranging from 4 to 37 C for at least 14 days, making local distribution of this vaccine feasible without refrigeration [134]